Transporting trial results to synthetic real-world populations in order to estimate real-world effectiveness of newly marketed medicines
Introduction Real-world effectiveness of a new treatment is relevant information for patients, healthcare professionals and payers, especially when patients encountered in routine clinical care differ significantly from those recruited in the randomised controlled trials (RCTs) that led to approval....
Saved in:
| Main Authors: | Walter E Haefeli, Ignacio Leiva-Escobar, Camilo Scherkl, Andreas D Meid |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-07-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/7/e089218.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Towards a prescribing monitoring system for medication safety evaluation within electronic health records: a scoping review
by: Camilo Scherkl, et al.
Published: (2025-07-01) -
Census and Analysis of Higher-Order Interactions in Real-World Hypergraphs
by: Xihang Meng, et al.
Published: (2025-04-01) -
Real-world characteristics and treatment patterns in Chinese patients with newly diagnosed endometrial cancer
by: Aijun Yin, et al.
Published: (2025-07-01) -
Psychiatry in the real world
by: Orestis Giotakos
Published: (2025-07-01) -
The role of real world data and real world evidence in health technology assessment
by: E. A. Novoderezhkina, et al.
Published: (2022-10-01)